title: Calcium mobilization by the plant estrogen ferutinin does not induce blood platelet aggregation.
abstract: Platelet activation is closely associated with an increase in intracellular Ca(2+) concentration. Various compounds including Ca(2+) ionophores are able to trigger platelet aggregation by increasing intracellular Ca(2+) concentration in platelets. In the present study, we monitored the effect of the phytoestrogen ferutinin, which acts as a Ca(2+) ionophore in human blood platelets; its ionophore-like properties include upregulation of [Ca(2+)](in), activation of fibrinogen receptors and increased fibrinogen binding. Using spectrofluorometry and triple-color flow cytometry, we demonstrate that ferutinin increases [Ca(2+)](in) in both isolated platelets and platelets in whole blood from humans. This effect was almost completely blocked by the Ca(2+) chelator EGTA and was not sensitive to either Gd(3+) or econazole, which inhibit VOC and SOC channels, respectively. Nor was the effect sensitive to thapsigargin, an inhibitor of endoplasmic reticulum Ca(2+) ATPases. Ferutinin stimulated the expression of the active form of the GPIIb-IIIa complex and whole blood platelet aggregation only weakly and had no statistically significant effect on the binding of fibrinogen. These results demonstrate apparently inconsistent effects of ferutinin, which raises intraplatelet Ca(2+) concentration but fails to have an effect on spontaneous blood platelet aggregation. This pattern of responses may be caused by the combination of ferutinin's Ca(2+) ionophoric and estrogenic properties.
authors.affiliation: Faculty of Biology and Chemistry, University of Bialystok, Świerkowa 20B, PL 15-950 Białystok, Poland.
authors.forename: Maria
authors.initials: M
authors.lastname: Zamaraeva
authors.forename: Oksana
authors.initials: O
authors.lastname: Charishnikova
authors.forename: Ashraf
authors.initials: A
authors.lastname: Saidkhodjaev
authors.forename: Valery
authors.initials: V
authors.lastname: Isidorov
authors.forename: Magdalena
authors.initials: M
authors.lastname: Granosik
authors.forename: Marcin
authors.initials: M
authors.lastname: Różalski
authors.forename: Cezary
authors.initials: C
authors.lastname: Watała
mesh_terms: D000244:Adenosine Diphosphate / Q000378:metabolism; D000328:Adult; D001565:Benzoates / Q000494:pharmacology*; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology; D002118:Calcium / Q000097:blood* / Q000378:metabolism; D003508:Cycloheptanes / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D008297:Male; D048789:Phytoestrogens / Q000494:pharmacology*; D010936:Plant Extracts / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D012717:Sesquiterpenes / Q000494:pharmacology*; D019284:Thapsigargin / Q000494:pharmacology
chemical_list: D001565:Benzoates; D001643:Bridged Bicyclo Compounds; D003508:Cycloheptanes; D004791:Enzyme Inhibitors; D048789:Phytoestrogens; D010936:Plant Extracts; D012717:Sesquiterpenes; C111068:4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en; D000244:Adenosine Diphosphate; D019284:Thapsigargin; D005340:Fibrinogen; D002118:Calcium